Search Within

Hematologic Malignancies, Division of

Formats
  1. Meeting Abstract (6372)
  2. Journal Article (5771)
  3. Review (420)
  4. Editorial (194)
  5. Book Section (188)
  6. Research Letter (179)
  7. Guidelines (88)
  8. Conference Paper (65)
  9. Correspondence (61)
  10. Miscellaneous (18)
  11. Book Whole (9)
Groups
  1. Department of Medicine (13264)
  2. Center for Hematologic Malignancies (10600)
  3. GSK Faculty (4479)
  4. Adult Leukemia (3669)
  5. Bone Marrow Transplant (2847)
  6. Lymphoma (2702)

More Groups

People
  1. Sergio Giralt (1068)
  2. Miguel-Angel Perales (943)
  3. Ross Levine (787)
  4. Andrew Zelenetz (784)
  5. Steven Horwitz (668)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (326)
  2. 2024 (823)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3528)
  2. Journal of Clinical Oncology (1233)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (329)
  5. Haematologica (291)
  6. Bone Marrow Transplantation (239)

More Publications

Publishers
  1. American Society of Hematology (3803)
  2. Elsevier Inc. (1529)
  3. American Society of Clinical Oncology (1288)
  4. Nature Publishing Group (1008)
  5. American Association for Cancer Research (641)
  6. Wiley Blackwell (433)

More Publishers

Results (13365)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NGS MRD negativity on day 28 after brexu cel in adults with R/R ALL is associated with favorable progression free survival
    Meeting Abstract

    Valtis, Y. K.; Nemirovsky, D.; Devlin, S. M.; Roloff, G. W.; Aldoss, I.; Jeyakumar, N.; Miller, K.; Zhang, A.; Sutherland, K. C.; Advani, A. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Comparative real-world outcomes of commercial CD19-directed CAR T-cell therapies in large B-cell lymphoma
    Meeting Abstract

    Deschè‚nes-Simard, X.; Bromberg, M.; Devlin, S. M.; Katz, O. B.; Ip, A.; Marcus, R.; Avigdor, A.; Ballweg, A.; Rabinovich, E.; Alhomoud, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Real-world characteristics and treatment patterns of transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, bortezomib, lenalidomide, and dexamethasone (DVRd) as front-line treatment: Results from a multicenter chart review study
    Meeting Abstract

    Tan, C. R.; Gordan, L.; Dileo, R.; Mewawalla, P.; Larson, S. M.; Davies, F. E.; Oveisi, D.; Gupta-Werner, N.; Medhekar, R.; Cortoos, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Racial differences in proportion of myeloma cases attributable to modifiable risk factors in the United States, 2016-21
    Meeting Abstract

    Anuraj, A.; Rath, D.; Derkach, A.; Usmani, S. Z.; Shah, U. A.
    Blood (2024)

    Fulltext@MSK | Save
  • A medical chart review of healthcare costs in patients with systemic amyloid light chain amyloidosis by Mayo 2012 stage in the United States
    Meeting Abstract

    Gertz, M. M. A.; Landau, H. J.; Sanchorawala, V.; Bhutani, M.; Zonder, J. A.; Rosenzweig, M.; Magee, G.; Campos, C.; Yermilov, I.; Chang, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Association between dose reduction and duration of therapy in patients receiving ibrutinib or acalabrutinib for chronic lymphocytic leukemia: A medical chart review study
    Meeting Abstract

    Shadman, M.; Roeker, L.; Pinilla-Ibarz, J.; Srivastava, B.; Karve, S.; Krigsfeld, G. S.; Franceschini, E.; Saifan, C.; Karanth, S.; Goyal, R. K.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • End-of-life care patterns in older patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting
    Meeting Abstract

    Hamlin, P. A.; Torka, P.; Hansen, E.; Belli, A. J.; Ambrose, J.; Zettler, C. M.; Fernandes, L. L.; Wiley, S.; Perry, B.; Wang, C. K.
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of health literacy in hematology outpatients receiving oral anticancer drugs and followed by the Oncoral multidisciplinary city-hospital educational follow-up
    Meeting Abstract

    Herledan, C.; Ranchon, F.; Preau, M.; Komaroff, A.; Guillemin, A.; Maire, M.; Ruiz-Caffin, A. G.; Karlin, L.; Ferrant, E.; Salles, G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Disparities in microbiota diversity impacting non-European recipients of 8/8 HLA-matched unrelated donor transplantation
    Meeting Abstract

    Smith, N. G.; Fingrut, W. B.; Waters, N.; Piasevoli, K.; Fei, T.; Slingerland, J.; Peled, J. U.; Ponce, D. M.
    Blood (2024)

    Fulltext@MSK | Save
  • A phase 1 study to evaluate the safety and tolerability of a combination autologous CD19 CART cell therapy (SYNCAR-001) and orthogonal IL-2 (STK-009) in subjects with relapsed or refractory CD19 expressing hematologic malignancies (NCT05665062)
    Meeting Abstract

    Palomba, M. L.; Caimi, P. F.; Mei, M.; Hernandez-Ilizaliturri, F.; Shouse, G.; Winter, A. M.; Yedinak, G.; Mou, D.; Huang, N.; Moua, A.; more...
    Blood (2024)

    Fulltext@MSK | Save